Article Versions Notes

Murányi J, Duró C, Gurbi B, Móra I, Varga A, Németh K, Simon J, Csala M, Csámpai A. Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms. International Journal of Molecular Sciences. 2023; 24(4):3456. https://doi.org/10.3390/ijms24043456

Murányi, József, Cintia Duró, Bianka Gurbi, István Móra, Attila Varga, Krisztina Németh, József Simon, Miklós Csala, and Antal Csámpai. 2023. "Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms" International Journal of Molecular Sciences 24, no. 4: 3456. https://doi.org/10.3390/ijms24043456

Murányi, J., Duró, C., Gurbi, B., Móra, I., Varga, A., Németh, K., Simon, J., Csala, M., & Csámpai, A. (2023). Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms. International Journal of Molecular Sciences, 24(4), 3456. https://doi.org/10.3390/ijms24043456